DETAILS, FICTION AND PEMBROLIZUMAB COST

Review Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indication: Together with chemotherapy, to the therapy of Grownup sufferers with regionally recurrent unresectable or metastatic triple-damaging breast cancer who've not acquired prior chemotherapy for metastatic disease and whose tumours express programmed cell Demise-ligand one (blended